Santarsieri, A., Mitchell, E., Pham, M. H., Sanghvi, R., Jablonski, J., Lee-Six, H., Sturgess, K., Brice, P., Menne, T. F., Osborne, W., Creasey, T., Ardeshna, K. M., Baxter, J., Behan, S., Bhuller, K., Booth, S., Chavda, N. D., Collins, G. P., Culligan, D. J., Cwynarski, K., …Follows, G. A. (in press). The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study. The Lancet Oncology, 26(1), 98-109. https://doi.org/10.1016/S1470-2045%2824%2900598-9